Eastern Kentucky Pharmacies and Treatment Programs to Pay Federal Government Over One Million Dollars to Settle Allegations of Improper Record…
Targeted News Service |
Eastern Kentucky Pharmacies and Treatment Programs to Pay Federal Government Over
"The regulatory scheme governing the handling of controlled substances is designed to insure that these powerful drugs are used only for appropriate medical purposes," said U.S. Attorney Harvey. "These vital safeguards are compromised and our communities are put at greater risk when medical professionals entrusted to prescribe or dispense these drugs do not meet their obligations under the Controlled Substances Act. The substantial penalties paid in these cases are consistent with the importance of strict compliance with the Controlled Substances Act by all DEA registrants."
The government contended that a DEA audit of the treatment programs and pharmacies revealed shortages and overages of prescription drugs and incomplete and inaccurate records. DEA agents found the facilities had improperly documented the type of drug, the dosage strength, the name of drugs, or the amount of the drugs they were dispensing. The investigations were initiated by the DEA's
Under federal law, the DEA supplies medical professionals with a registration number that authorize them to possess, prescribe and dispense certain controlled substances, such as Methadone, Oxycodone, Hydrocodone, Lortab and others. The DEA also has the authority to perform audits and inspections to ensure that clinics, pharmacies and treatment programs properly document drug transactions, including the amount of controlled substances dispensed, discarded, and received.
Assistant U.S. Attorney
CC AutoTriage6yd-140816-30VitinMar-4830577
Copyright: | (c) 2014 Targeted News Service |
Wordcount: | 455 |
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News